Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Targeting Aldose Reductase for the Treatment of Cancer

Volume:11   Issue:5
Pp: 560-571
R. Tammali, S. K. Srivastava and K. V. Ramana
DOI: 10.2174/156800911795655958

CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

Volume:11   Issue:5
Pp: 572-585
A. Serafino, M. Zonfrillo, F. Andreola, R. Psaila, L. Mercuri, N. Moroni, D. Renier, M. Campisi, C. Secchieri and P. Pierimarchi
DOI: 10.2174/156800911795655976

The Centrosome: A Target for Cancer Therapy

Volume:11   Issue:5
Pp: 600-612
M. Mazzorana, G. Montoya and G. B. Mortuza
DOI: 10.2174/156800911795655949

Drug Resistance: Challenges to Effective Therapy

Volume:11   Issue:5
Pp: 613-623
M. P.V. Shekhar
DOI: 10.2174/156800911795655921

VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future

Volume:11   Issue:5
Pp: 624-653
P. S. Sharma, R. Sharma and T. Tyagi
DOI: 10.2174/156800911795655985